Ruben Duijvenvoorde

Manager Distribution & Commercial QA at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Ruben Duijvenvoorde's Colleagues at Alnylam Pharmaceuticals
Jorge Castro

Sr Quality Operations Manager & QP at Alnylam Pharmaceuticals

Contact Jorge Castro

Karien Verhulst

Director, Medical Research

Contact Karien Verhulst

Michelle Van

Manager QA, Quality Systems and External Quality

Contact Michelle Van

Jessica Canseco

EU Manager Learning Capabilities & Technology

Contact Jessica Canseco

Tomas Björklund

Associate Director Regulatory Affairs

Contact Tomas Björklund

Shigeki Kawazoe

Associate Director, Business Commercial Operation Dept.

Contact Shigeki Kawazoe

View All Ruben Duijvenvoorde's Colleagues
Ruben Duijvenvoorde's Contact Details
HQ
(617) 551-8200
Location
The Hague Area, Netherlands
Company
Alnylam Pharmaceuticals
Ruben Duijvenvoorde's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Ruben Duijvenvoorde
Ruben Duijvenvoorde currently works for Alnylam Pharmaceuticals.
Ruben Duijvenvoorde's role at Alnylam Pharmaceuticals is Manager Distribution & Commercial QA.
Ruben Duijvenvoorde's email address is ***@alnylam.com. To view Ruben Duijvenvoorde's full email address, please signup to ConnectPlex.
Ruben Duijvenvoorde works in the SaaS industry.
Ruben Duijvenvoorde's colleagues at Alnylam Pharmaceuticals are Jorge Castro, Karien Verhulst, Michelle Van, Jessica Canseco, Mitchell Vorstman, Tomas Björklund, Shigeki Kawazoe and others.
Ruben Duijvenvoorde's phone number is (617) 551-8200
See more information about Ruben Duijvenvoorde